BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30310249)

  • 1. Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease.
    Khan MB; Palaka BK; Sapam TD; Subbarao N; Ampasala DR
    Bioinformation; 2018; 14(8):414-428. PubMed ID: 30310249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors.
    Şahİn K; DurdaĞi S
    Turk J Chem; 2020; 44(3):574-588. PubMed ID: 33488178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity.
    Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V
    J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
    Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
    J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: Synthesis, computational and pharmacological study.
    Jevtić II; Suručić RV; Tovilović-Kovačević G; Zogović N; Kostić-Rajačić SV; Andrić DB; Penjišević JZ
    Bioorg Med Chem; 2024 Mar; 101():117649. PubMed ID: 38401458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation.
    Remya C; Dileep KV; Koti Reddy E; Mantosh K; Lakshmi K; Sarah Jacob R; Sajith AM; Jayadevi Variyar E; Anwar S; Zhang KYJ; Sadasivan C; Omkumar RV
    Comput Struct Biotechnol J; 2021; 19():4517-4537. PubMed ID: 34471497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning.
    Kabir MT; Uddin MS; Begum MM; Thangapandiyan S; Rahman MS; Aleya L; Mathew B; Ahmed M; Barreto GE; Ashraf GM
    Curr Pharm Des; 2019; 25(33):3519-3535. PubMed ID: 31593530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
    Fernández-Bachiller MI; Pérez C; Monjas L; Rademann J; Rodríguez-Franco MI
    J Med Chem; 2012 Feb; 55(3):1303-17. PubMed ID: 22243648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease.
    Jangid K; Devi B; Sahoo A; Kumar V; Dwivedi AR; Thareja S; Kumar R; Kumar V
    J Biomol Struct Dyn; 2024; 42(1):509-527. PubMed ID: 37114423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors.
    Atanasova M; Dimitrov I; Ivanov S; Georgiev B; Berkov S; Zheleva-Dimitrova D; Doytchinova I
    Molecules; 2022 May; 27(10):. PubMed ID: 35630613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile.
    Remya C; Dileep KV; Tintu I; Variyar EJ; Sadasivan C
    J Mol Model; 2013 Mar; 19(3):1179-94. PubMed ID: 23229229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays.
    Sahin K; Zengin Kurt B; Sonmez F; Durdagi S
    J Biomol Struct Dyn; 2020 Jul; 38(11):3342-3358. PubMed ID: 31462153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).
    McHardy SF; Wang HL; McCowen SV; Valdez MC
    Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-
    Adeowo FY; Ejalonibu MA; Elrashedy AA; Lawal MM; Kumalo HM
    J Biomol Struct Dyn; 2021 Jul; 39(11):3825-3841. PubMed ID: 33030113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ajmalicine and its Analogues Against AChE and BuChE for the Management of Alzheimer's Disease: An
    Liu S; Dang M; Lei Y; Ahmad SS; Khalid M; Kamal MA; Chen L
    Curr Pharm Des; 2020; 26(37):4808-4814. PubMed ID: 32264807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
    Matošević A; Opsenica DM; Spasić M; Maraković N; Zandona A; Žunec S; Bartolić M; Kovarik Z; Bosak A
    Chem Biol Interact; 2023 Sep; 382():110620. PubMed ID: 37406982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.